QinetiQ Group PLC — Investor Relations & Filings
QinetiQ Group PLC is a science and engineering company that provides technology-based products and services primarily to the global defence and security sectors. The company's core activities include research and development, advisory services, and comprehensive test and evaluation (T&E) for air, land, and maritime systems. Key offerings encompass uncrewed air, land, and surface target systems for live-fire training and weapons system assessment; cybersecurity services and training; and advanced training and mission rehearsal solutions. QinetiQ focuses on mission-led innovation, applying its expertise to modernize military platforms and enhance critical technologies to address complex operational challenges for its customers.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Transaction in Own Shares | 2026-05-05 | English | |
| Total Voting Rights | 2026-04-30 | English | |
| Transaction in Own Shares | 2026-04-28 | English | |
| Transaction in Own Shares | 2026-04-21 | English | |
| Transaction in Own Shares | 2026-04-14 | English | |
| Director/PDMR Shareholding | 2026-04-10 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41305975 | Transaction in Own Shares | 2026-05-05 | English | ||
| 39110066 | Total Voting Rights | 2026-04-30 | English | ||
| 37867061 | Transaction in Own Shares | 2026-04-28 | English | ||
| 34696665 | Transaction in Own Shares | 2026-04-21 | English | ||
| 34655068 | Transaction in Own Shares | 2026-04-14 | English | ||
| 34088310 | Director/PDMR Shareholding | 2026-04-10 | English | ||
| 33558607 | Director/PDMR Shareholding | 2026-04-01 | English | ||
| 33117229 | Total Voting Rights | 2026-03-31 | English | ||
| 33084543 | Transaction in Own Shares | 2026-03-30 | English | ||
| 33039702 | Holding(s) in Company | 2026-03-25 | English | ||
| 33037959 | Share Buyback Programme | 2026-03-25 | English | ||
| 33037721 | Transaction in Own Shares | 2026-03-25 | English | ||
| 33018331 | Transaction in Own Shares | 2026-03-24 | English | ||
| 33011138 | Transaction in Own Shares | 2026-03-23 | English | ||
| 32996656 | Transaction in Own Shares | 2026-03-20 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for QinetiQ Group PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
|
Alpha Tau Medical Ltd.
Clinical-stage oncology firm developing alpha radiation the…
|
DRTS | US | Professional, scientific and te… |
QinetiQ Group PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/4849/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=4849 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=4849 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=4849 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 4849}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for QinetiQ Group PLC (id: 4849)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.